ISO 10993 Biocompatibility
Consulting for Medical Devices
MedDev Advisory helps medical-device teams plan biological evaluations, assess evidence gaps and prepare clear, device-specific ISO 10993 documentation.
Typical High-Priority Projects
Where teams usually need help fast
Aligned with the frameworks reviewers actually scrutinize
Built for teams that need a clear submission path, not generic template writing
MedDev Advisory typically supports teams that already have a device, a regulatory target, and a concrete documentation problem to solve.
MedTech Startups
Founders and first-time submission teams that need a defensible BEP, BER, or biocompatibility plan from scratch.
RA/QA Teams
Regulatory and quality teams that need expert support on endpoint strategy, waiver justification, or document review before submission.
Manufacturers Updating Legacy Files
Companies upgrading older BEPs and BERs to align with ISO 10993-1:2025, lifecycle framing, and current reviewer expectations.
Submission Consultants
Consultants and cross-functional teams that need specialist ISO 10993 input for FDA, EU MDR, or deficiency-response packages.
Best when these details are already clear
These details help define the documentation scope and identify evidence gaps.
If details are missing, tell us what is still open.
Supported Device Categories
If your device touches, implants into, or communicates with the human body — MedDev Advisory can prepare the biological evaluation documentation.
Implantable, Orthopaedic & Dental Devices
Long-term implants, bone-contacting fixation systems, and oral-contact devices requiring rigorous endpoint strategy, material evidence, and biological-risk reasoning. See the implantable-device support scope.
Catheters, Tubing & Cardiovascular Devices
Direct or indirect blood-contact and fluid-path devices where shafts, hubs, connectors, coatings, adhesives, and lubricants must be assessed together. Read the catheter and fluid-path guide.
Wound Care & Skin-Contact Devices
Dressings, wearable interfaces, and other surface-contacting devices where intact skin, breached tissue, released substances, adhesives, and repeated wear change the evidence question. Read the wound-dressing guide.
Diagnostic, IVD-Adjacent & Ophthalmic Devices
Patient-contacting biosensors, imaging probes, electrodes, and ocular devices where the interface—not only the instrument label—defines the biological-evaluation scope. See the biosensor support page.
Not sure if your device fits? Send a brief description — proposed scope and timing are agreed before work begins. No obligation to proceed.
ISO 10993 & Regulatory Services
Core ISO 10993 drafting, gap analysis, and submission remediation for teams preparing CE Mark, FDA, and India pathways.
Biological Evaluation Plan (BEP)
ISO 10993-1:2018/2025 endpoint strategy. Indicative working window: 3–5 business days after complete inputs, confirmed in the proposal.
View dedicated BEP service page Already have a draft? Use the BEP review service Need a no-new-testing rationale? View test-waiver support ISO 10993-1:2025Biological Evaluation Report (BER)
Literature evaluation, existing-data assessment, and risk-based conclusions. Indicative working window: 5–7 business days after complete inputs, confirmed in the proposal.
View dedicated BER service page Already have a draft? Use the BER review service ISO 10993-1:2025Toxicological Risk Assessment (TRA)
AET/TTC calculations per ISO 10993-17 and ISO 10993-18 for extractables and leachables.
Read how TRA supports modern biological evaluation ISO 10993-17/18ISO 10993-1:2025 Gap Analysis
Assess existing BEP/BER documentation against the updated 2025 requirements. Identify and resolve gaps.
View dedicated gap-analysis page 2025 UpdateMaterial Change Biocompatibility Assessment
Structured change-impact review for supplier, formulation, coating, sterilization, process, packaging, and design changes.
View dedicated material-change page Change ControlImplantable Device Biocompatibility Support
ISO 10993 support for implantable devices, implantable biosensors, long-term endpoint strategy, and file remediation.
View dedicated implantable-device page High-risk devicesBiocompatibility Documentation Review
Best first step when a BEP, BER, TRA, or summary section already exists and needs a specialist check before submission.
Use the review as your first step Pre-submissionEU MDR Technical File — Biocompatibility Section
Biocompatibility documentation addressing applicable Annex I GSPR §10 requirements for the CE Mark technical file.
View dedicated EU MDR support page EU MDRNotified Body Query Response
Point-by-point remediation for BEP, BER, waiver, materials, and Annex I gaps raised during CE Mark review.
View dedicated notified body response page CE Mark RemediationFDA 510(k) Biocompatibility Section
Uses FDA's final September 2023 biocompatibility guidance together with current recognition records and applicable device-specific sources.
View dedicated FDA support page Responding to an FDA request? Read the remediation guide FDA 510(k)CDSCO Strategy & Documentation Support
India pathway planning, documentation readiness, and biocompatibility-linked submission strategy. Indian manufacturers and export-oriented startups can also start with the broader quality-readiness vertical.
India quality and biocompatibility readiness View dedicated CDSCO support page India / CDSCOBiocompatibility Documentation Review
Best first step when a draft file already exists and the team needs to know whether it is usable, weak in key places, or headed toward reviewer friction.
See how the review is packaged Pre-submissionRelated work on CER, PMCF/PMS, and scientific writing is scoped to the biological-evaluation evidence needed for your submission.
Biological-Evaluation Work Grounded in Research
MedDev Advisory applies biomaterials research and ISO 10993 expertise to device-specific biological evaluations.
Evidence Matched to Your Device
Build the evaluation around the device’s materials, patient contact and manufacturing context. Available reports and supplier records are reviewed together, with assumptions, missing inputs and evidence gaps made explicit.
A Clear Biological Evaluation Plan
Organise the endpoint questions, existing evidence and potential testing needs within the agreed ISO 10993 scope. The plan sets out the next steps, their scientific rationale and any unresolved evidence gaps.
Scientific Reasoning Reviewers Can Follow
Connect findings and conclusions to their supporting sources. Literature, material information and relevant test results are assessed together, with uncertainties and the limits of the available evidence kept visible.
Scope and Delivery Agreed Upfront
Agree the inputs, deliverables, formats, schedule and revision terms in writing before work starts. Delivery follows the confirmed scope and available inputs, with changes discussed when new evidence affects the work.
Support for Your Target Market
Organise biological evidence for the agreed target-market pathway using applicable requirements and current primary sources. The scope makes clear where specialist input is needed and which responsibilities remain with the manufacturer.
Arvind Rathore
ISO 10993 Biocompatibility Consultant
The Biological Evaluation Strategy Handbook
Connect device facts and evidence gaps to a clear biological evaluation plan and report under ISO 10993-1:2025.
For professionals planning, reviewing or documenting biological evaluation. Read the real sample before requesting the exact licence offer.
Browse all five current professional booksFrom First Discussion to Final Delivery
Clear scope, agreed deliverables and a structured review process for your medical device.
Share Your Requirements
Tell us about your device, target market, available evidence and timeline so we can identify the right support.
Agree the Scope
Receive a written proposal defining the deliverables, fees, timeline and review rounds before work begins.
Evidence Review & Drafting
MedDev Advisory reviews the available evidence and prepares the agreed assessment or documentation for your device.
Review & Delivery
Review the draft, provide consolidated feedback and receive the agreed final documents in Word and PDF.
Timelines start after complete inputs and are confirmed for the agreed scope in the written proposal.
Biological Evaluation Examples
Explore illustrative approaches to biological evaluation planning, evidence gaps and reviewer questions.
Implantable Biosensor — BEP and BER
A long-term implant needs a consistent evidence trail. Align the device description, chemistry, biological effects and uncertainties across the BEP and BER for review.
Vascular Catheter — FDA Response
An FDA query identifies gaps in cytotoxicity-extract rationale and polymer-hub chemistry. Review the missing evidence and prepare clear, endpoint-specific response rationales.
Wound Dressing — Legacy BER Review
When reviewing a 2018-edition BER against the 2025 framework, identify relevant gaps, retain applicable evidence and prioritise updates to lifecycle, uncertainty and benefit-risk reasoning.
Core Frameworks & Standards
Biological Evaluation Series
- Part 1: Evaluation & Testing (2018 & 2025)
- Part 5: Cytotoxicity
- Parts 10 & 23: Sensitization & Irritation
- Part 17: Toxicological Risk Assessment
- Part 18: Chemical Characterization
EU MDR 2017/745
- Annex I — GSPR §10 Biocompatibility
- Annex II — Biocompatibility Evidence
- Annex III — Biological Safety in PMS
- Biological Safety Evidence for CER
- Biological Safety Evidence for PMCF
FDA Biological Evaluation
- FDA final ISO 10993-1 guidance (September 2023)
- 510(k) Biocompatibility Section
- De Novo Biocompatibility Support
- PMA Biocompatibility Support
- FDA Biocompatibility Responses
Biological Risk & QMS
- Biocompatibility within ISO 13485:2016
- ISO 14971:2019 Risk Management
- Risk-Based Biocompatibility Strategy
- Biological-Evaluation Change Control
- Biological Safety Evidence for CAPA
How to Get Started
Choose support for an existing draft, a new evaluation, or reviewer questions.
Submission Gap Review
Identify what needs attention in an existing BEP, BER, or TRA.
- Review of your existing BEP, BER, or TRA
- Written findings and evidence gaps
- Recommended ISO 10993 updates
- Check against the agreed target market
- One follow-up discussion
Full Documentation Draft
Prepare an agreed document from device records and available evidence.
- BEP, BER, or TRA drafted to agreed scope
- Applicable ISO 10993 considerations
- Testing or waiver rationale where supported
- Structure for the agreed target market
- Word + PDF and one agreed revision
Deficiency Remediation
Address FDA or notified body questions with a focused response.
- Assessment of reviewer questions
- Point-by-point draft response
- Agreed BEP or BER section updates
- Evidence gaps and required actions
- Structured response and one agreed revision
Estimates start after complete inputs; scope and timing are confirmed in the written proposal. TRA and complex cases are scoped separately.
Share your situation to confirm the likely scope and next step. If only the plan needs checking, explore the BEP review service.
Questions teams ask before they start a scope
The fastest way to move forward is to clarify whether you need a new BEP, a document review, or a cleanup of a file that already exists.
Do we need all testing complete before a BEP is written?
No. A strong BEP usually comes first. It sets the endpoint strategy, the evidence path, and where existing data or waivers may be enough.
View BEP serviceWhat makes a BEP look generic to a reviewer?
Usually vague device framing, copied endpoint tables, and waiver logic that is asserted without a clear scientific basis tied to the actual device.
Read the BEP mistakes articleWhat if we already have a draft BEP, BER, or TRA?
That is often a review problem, not a rewrite problem. A fast gap review can show whether the file needs selective remediation or deeper restructuring.
Start with a gap reviewWhat information helps scope the work fastest?
Device description, contact type and duration, materials, current documents, and the target pathway. With that, the next step is usually clear quickly.
Send a project briefHow quickly will we know the right next step?
Usually once the device context and current file state are reviewed, it becomes clear whether the right move is a BEP, a BER review, a gap review, or a broader consulting scope.
Share the current file stateWhat if we are not sure whether we need a BEP, BER, or TRA?
That is common. The first job is often to classify the problem correctly so you do not spend time rewriting the wrong document or ordering the wrong next step.
Use a gap review to decideWhat is MedDev Advisory?
MedDev Advisory is an independent ISO 10993 biocompatibility consulting practice led by Arvind Rathore for medical-device documentation and reviewer-facing file work.
Read about MedDev AdvisoryWho founded MedDev Advisory?
MedDev Advisory was founded and is led by Arvind Rathore, a medical-device biocompatibility consultant with biomaterials, ISO 10993, and implantable biosensor research experience.
View Arvind's backgroundWhat services does MedDev Advisory provide?
The core work covers ISO 10993 biological evaluation strategy, BEP, BER, TRA, EU MDR biocompatibility sections, FDA 510(k) support, and selected India / CDSCO documentation.
View service optionsIs MedDev Advisory affiliated with ISO, FDA, EU authorities, CDSCO, or notified bodies?
No. MedDev Advisory is an independent consulting practice and is not affiliated with, endorsed by, or approved by ISO, FDA, EU authorities, notified bodies, CDSCO, or the Government of India.
Read the disclaimerUseful starting points: the ISO 10993 strategy guide, the practical ISO 10993-1:2025 gap checklist, and the chemical characterization support page for chemistry-driven files.
Latest Insights
Expert articles and regulatory updates on ISO 10993, EU MDR, FDA, and India topics — written by a practising consultant, not a template library.
Catheter and Fluid-Path Biocompatibility
When shafts, lumens, hubs, connectors, valves, adhesives, and lubricants create direct or indirect patient-exposure questions.
Reusable-Instrument Biocompatibility After Reprocessing
How cleaning, disinfection, sterilization, and repeated use can affect residues, surfaces, representative states, and biological evidence.
Wearable Electrode and Skin-Contact Biocompatibility
A practical guide to adhesives, hydrogels, conductive materials, repeated wear, and the limits of FDA intact-skin policy.
Biocompatibility Test Article Preparation
How to connect the final finished device, sterilization, aging, specimen preparation and extraction inputs to a defensible test record.
How to Select a Worst-Case Representative Device
A question-led method for comparing device-family materials, processing, geometry, exposure and evidence gaps without a universal score.
Wound Dressing Biocompatibility: Intact vs Breached Skin
How mixed-contact dressings create separate questions for intact skin, injured surfaces, released substances, duration and evidence planning.
Preparing a Biological Evaluation?
Request a Scoping Review.
Whether you're preparing an initial BEP, responding to a notified body query, or updating legacy documentation to ISO 10993-1:2025, send the project context and MedDev Advisory will outline the likely scope, priorities, and next step before any engagement.
MedDev Advisory responds within 24 hours on business days